IPO Singular Genomics Systems Raises $258M in Upsized IPO The San Diego-based sequencing technology firm added nearly 2 million shares on the eve of its IPO, and its shares rose 17 percent on the first day of trading. Singular Genomics Ups IPO Target to $187M The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation. Sequencing Startup Singular Genomics Files for $100M IPO The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis. Post-IPO, Talis Biomedical Looks Toward Expanding Infectious Disease Test Portfolio Premium The firm will submit its SARS-CoV-2 test and Talis One instrument to the US Food and Drug Administration for Emergency Use Authorization in the second quarter. Oxford Nanopore Technologies to File for IPO in Second Half of 2021 IP Group, which holds a 15 percent stake in Oxford Nanopore, said it currently values the company at £2.27 billion ($3.11 billion). Mar 12, 2021 Prometheus Biosciences Prices Upsized $190M IPO Mar 3, 2021 Olink Files For Public Offering in US Feb 26, 2021 Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster Premium Feb 19, 2021 NRGene Looks to Royalty-Based Partnerships in Wake of IPO Premium Feb 18, 2021 Cancer Screening Test Developer New Horizon Health Goes Public in Hong Kong Feb 18, 2021 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO Feb 5, 2021 At-Home Infectious Disease Test Developer Lucira Health Goes Public at $17 Per Share Jan 26, 2021 NRGene Completes $30.6M IPO Jan 25, 2021 Infectious Disease Test Firm Talis Biomedical Files for IPO Jan 19, 2021 Lucira Health Files for $115M IPO Dec 18, 2020 Miniature Mass Spec Firm 908 Devices Prices $130M IPO Nov 30, 2020 Mini Mass Spec Firm 908 Devices Files for IPO Oct 28, 2020 Biodesix Prices $72M IPO Oct 5, 2020 Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells Premium Sep 14, 2020 Grail Plans Additional Liquid Biopsy Tests for Cancer Detection, Monitoring Premium Sep 9, 2020 Early Cancer Detection Firm Grail Files for IPO Aug 25, 2020 Berkeley Lights Q2 Revenues Fall 10 Percent Jul 17, 2020 Berkeley Lights Prices Upsized $178.2M IPO Jul 13, 2020 Berkeley Lights to Raise up to $153M in IPO Jun 22, 2020 Burning Rock Raises $281.2M Through IPO, Private Placement Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.